Ed Beveridge Shares A New Guide on VTE Prophylaxis in Psychiatric Illness
Ed Beveridge, Clinical Director at North London NHS Foundation Trust, shared on LinkedIn:
”NEW GUIDELINE ALERT
Patients in mental health inpatient settings can be at significant risk of venous thromboembolism (VTE) and Deep Vein Thrombosis (DVT) and Pulmonary Embolus (PE) are potential causes of avoidable harm and even death.
Standard risk assessments recommended by national guidance do not perform well in our settings – until now.
Very excited to see this new guidance, evidence based and designed specifically for our patients, published this week.
It has the potential to make real-life improvements in outcomes for our patients – I hope it will become standard as part of our physical health screening processes in mental health settings.
Congratulations to the authors on this very imporatant internationall collaboration Audrey Purcell, Arnav Agarwal, Josie Jenkinson and others.”
Read the full article here.
Article: Venous thromboembolism prophylaxis in adults hospitalised for psychiatric illness: an evidence-based clinical practice guideline developed using GRADE
Authors: Audrey Purcell, Fionnuala Ní Áinle, Beverley J. Hunt, Aurelien Delluc, Lara Roberts, Josie Jenkinson, Jennifer Hoblyn, Dolores Keating, Aoife Carolan, Eric Roche, Kathy Morgan, Richard Duffy, Sarah Garvey, Joanne Flood, Ann Marie O′ Neill, Arnav Agarwal

Stay updated on all scientific advances with Hemostasis Today.
-
Sep 15, 2026, 01:37Lesley Van Wyk: Exploring Sickle Cell Disease – The HbS Story
-
Sep 15, 2026, 01:31Luca Seffin: To the Science, the People, and the Journey – Thank You SR-Tiget
-
Sep 14, 2026, 23:49Heghine Khachatryan: New evidance – Antiphospholipid Antibodies and Ischemic Stroke
-
Sep 14, 2026, 23:42Eman M. Elsabbagh: Successful HCT Does Not End at Engraftment
-
Sep 14, 2026, 23:31Antonis Kattamis: Proud to Be Part of this Endeavour and Senior Author of the Pivotal Trial
-
Sep 14, 2026, 23:23Farjah Algahtani: Stroke Incidence and Risk Factors in Saudi Patients with Sickle Cell Disease
-
Sep 14, 2026, 20:53YoonHwa An: Rusfertide in Polycythemia Vera – From Clinical Benefit to Strategic Value
-
Sep 14, 2026, 20:52Andres Alberto Mercado Pompa: External Validation of Prognostic Risk Scores in Cerebral Venous Thrombosis
-
Sep 14, 2026, 20:50Balaji Kirushnan: Advancing Regional Citrate Anticoagulation in CRRT – From Experience to Implementation